Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-02

Clinical Trial Update: Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the combination of pemetrexed (Alimta) and carboplatin with radiation therapy in patients with inoperable non-small cell lung cancer a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alimta (pemetrexed)
  • CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Inoperable Non Small Cell Lung Cancer | Phase 1 | Status: COMPLETED